Development of a therapeutic vaccine targeting Merkel cell polyomavirus capsid protein VP1 against Merkel cell carcinoma
Abstract Merkel cell carcinoma (MCC) is a rare but aggressive skin cancer with a high mortality rate, while Merkel cell polyomavirus (MCV) has been pointed as the causative agent of MCC. A better prognosis of MCC associated with a high level of antibodies against the capsid protein VP1 suggests that...
Guardado en:
Autores principales: | Dan Xu, Sheng Jiang, Yue He, Xiang Jin, Gan Zhao, Bin Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3588ab04983146199e8e9fd7efbb1b2b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Merkel cell polyomavirus minor capsid protein.
por: Rachel M Schowalter, et al.
Publicado: (2013) -
Epigenetic Dysregulations in Merkel Cell Polyomavirus-Driven Merkel Cell Carcinoma
por: John Charles Rotondo, et al.
Publicado: (2021) -
Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma.
por: Hélène C Laude, et al.
Publicado: (2010) -
Response of Merkel cell polyomavirus-positive merkel cell carcinoma xenografts to a survivin inhibitor.
por: Lindsay R Dresang, et al.
Publicado: (2013) -
Quantitation of human seroresponsiveness to Merkel cell polyomavirus.
por: Diana V Pastrana, et al.
Publicado: (2009)